Drug
Pill Placebo
Pill Placebo is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
83%(5 trials)
Phase Distribution
Ph not_applicable
1
17%
Ph phase_2
1
17%
Ph phase_3
3
50%
Ph early_phase_1
1
17%
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
3(50.0%)
N/ANon-phased studies
1(16.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 33 (50.0%)
N/A1 (16.7%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedearly_phase_1
Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine
NCT01944423
completedphase_2
Combined Treatment for Alcohol-Dependent Individuals With PTSD
NCT00262223
completedphase_3
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
NCT01411774
completednot_applicable
Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
NCT02317744
completedphase_3
Treatments for Depression: Drug Versus Psychotherapy
NCT00043550
Clinical Trials (6)
Showing 6 of 6 trials
NCT01944423Early Phase 1
Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine
NCT00262223Phase 2
Combined Treatment for Alcohol-Dependent Individuals With PTSD
NCT01411774Phase 3
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
NCT02317744Not Applicable
Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
NCT00043550Phase 3
Treatments for Depression: Drug Versus Psychotherapy
NCT00043537Phase 3
Treatment of Childhood Social Phobia
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6